14.1 Donor malignancies known to be transmitted or known not to be transmittedby cancer, organ and cell type 14.2 Providing guidance on early detection and prevention of transmission 14.3 Providing guidance on intermediate steps to take for index recipient and other potentially affected recipients 14.4 Providing guidance on steps to investigate and confirm the imputability of malignancy transmission ‹ 13.1 The Graft Recipient and the Presentation of Allograft-Associated Infections up 14.1 Donor malignancies known to be transmitted or known not to be transmittedby cancer, organ and cell type ›